Assessing disease activity in ulcerative colitis: Patients or their physicians?

Inflammatory Bowel Diseases

Volumn 16, Issue 4, 2010, Pages 651-656

  Turner, Dan ^a   Griffiths, Anne M ^b   Mack, David ^c   Otley, Anthony R ^d   Seow, Cynthia H ^e   Steinhart, A Hillary ^e   Silverberg, Mark S ^e   Hyams, Jeffrey ^f   Guyatt, Gordon H ^g  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d IWK HEALTH CENTRE   (Canada)

^e MOUNT SINAI HOSPITAL   (Canada)

^f Farmington   (United States)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Assessment of health status; Disease activity; Ulcerative colitis

Indexed keywords

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BIOLOGICAL ACTIVITY; CHILD; CLINICAL RESEARCH; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC ACCURACY; DISEASE ACTIVITY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INFORMATION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; PARENT; PEDIATRICS; PHYSICIAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; ULCERATIVE COLITIS; VALIDITY; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ATTITUDE TO HEALTH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PATIENTS; PERCEPTION; PHYSICIANS; PROSPECTIVE STUDIES; QUESTIONNAIRES; YOUNG ADULT;

EID: 77949513296     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21088     Document Type: Article

References (39)

1. D'Haens G, Sandborn WJ, Feagan BG, et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology.2007;132:763-786.
2. Turner D, Otley AR, Mack D, et al. Development and evaluation of a Pediatric Ulcerative Colitis Activity Index (PUCAI): a prospective multicenter study. Gastroenterology. 2007;133:423-432.
3. Higgins PD, Schwartz M, Mapili J, et al. Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis. Gut. 2005;54:782-788.
4. Joyce JC, Waljee AK, Khan T, et al. Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity. Health Qual Life Outcomes. 2008;6:69.
5. Schachter H, Kirsner JB. Definitions of inflammatory bowel disease of unknown etiology. Gastroenterology. 1975;68:591-600.
6. Otley A, Smith C, Nicholas D, et al. The IMPACT questionnaire: a valid measure of health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2002;35:557-563.
7. Guyatt GH, Juniper EF, Griffith LE, et al. Children and adult perceptions of childhood asthma. Pediatric. 1997;99:165-168.
8. Beattie RM, Nicholls SW, Domizio P, et al. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroenterol Nutr. 1996;22:373-379.
9. Mary JY, Modigliani R. Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID). Gut. 1989;30:983-989.
10. Gomes P, du Boulay C, Smith CL, et al. Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986;27:92-95.
11. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. N Engl J Med. 1987;317:1625-1629.
12. David FN. The moments of the Z and F distributions. Biometrik. 1949;36:394-403.
13. Chalmer BJ. Understanding statistics. Boca Raton, FL: CRC Press; 1986: 294.
14. Yen JC, Abrahamowicz M, Dobkin PL, et al. Determinants of discordance between patients and physicians in their assessment of lupus disease activity. J Rheumatol. 2003;30:1967-1976.
15. Neville C, Clarke AE, Joseph L, et al. Learning from discordance in patient and physician global assessments of systemic lupus erythematosus disease activity. J Rheumatol. 2000;27:675-679.
16. Wright JG, Feinstein AR. A comparative contrast of clinimetric and psychometric methods for constructing indexes and rating scales. J Clin Epidemiol. 1992;45:1201-1218.
17. Norman GR, Stratford P, Regehr G. Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol. 1997;50:869-879.
18. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10:407-415.
19. Turner D, Schünemann HJ, Griffith LE, et al. The minimal detectable change cannot reliably replace the minimal important difference. J Clin Epidemiol. 2009 (in press).
20. Schunemann HJ, Puhan M, Goldstein R, et al. Measurement properties and interpretability of the chronic respiratory disease questionnaire (CRQ). COPD. 2005;2:81-89.
21. Schunemann HJ, Griffith L, Jaeschke R, et al. A comparison of the original chronic respiratory questionnaire with a standardized version. Chest. 2003;124:1421-1429.
22. Jacobs JW, Oosterveld FG, Deuxbouts N, et al. Opinions of patients with rheumatoid arthritis about their own functional capacity: how valid is it? Ann Rheum Dis. 1992;51:765-768.
23. Pincus T, Strand V, Koch G, et al. An index of the three core data set patient questionnaire measures distinguishes efficacy of active treatment from that of placebo as effectively as the American College of Rheumatology 20% response criteria (ACR20) or the Disease Activity Score (DAS) in a rheumatoid arthritis clinical trial. Arthritis Rheum. 2003;48:625-630.
24. Wyrwich KW, Wolinsky FD. Identifying meaningful intra-individual change standards for health-related quality of life measures. J Eval Clin Pract. 2000;6:39-49.
25. Berkanovic E, Hurwicz ML, Lachenbruch PA. Concordant and discrepant views of patients' physical functioning. Arthritis Care Res. 1995;8:94-191.
26. Kwoh CK, O'Connor GT, Regan-Smith MG, et al. Concordance between clinician and patient assessment of physical and mental health status. J Rheumatol. 1992;19:1031-1037.
27. Hidding A, van Santen M, De Klerk E, et al. Comparison between self-report measures and clinical observations of functional disability in ankylosing spondylitis, rheumatoid arthritis and fibromyalgia. J Rheumatol. 1994;21:818-823.
28. Calkins DR, Rubenstein LV, Cleary PD, et al. Failure of physicians to recognize functional disability in ambulatory patients. Ann Intern Med. 1991;114:451-454.
29. Slevin ML, Plant H, Lynch D, et al. Who should measure quality of life, the doctor or the patient? Br J Cancer. 1988;57:109-112.
30. Canonica GW, Baena-Cagnani CE, Blaiss MS, et al. Unmet needs in asthma: Global Asthma Physician and Patient (GAPP) Survey: global adult findings. Allergy. 2007;62:668-674.
31. Rothwell PM, MacDowell Z, Wong CK, et al. Doctors and patients don't agree: cross sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis. Br Med J. 1997;314:1580-1583.
32. Kennedy AP, Nelson E, Reeves D, et al. A randomised controlled trial to assess the effectiveness and cost of a patient orientated self management approach to chronic inflammatory bowel disease. Gut. 2004;53:1693-1645.
33. Feinstein AR. Clinimetrics. New Haven, CT: Yale University Press; 1987.
34. Feinstein AR. "Clinical judgment" revisited: the distraction of quantitative models. Ann Intern Med. 1994;120:799-805.
35. Feinstein AR. Nomenclature and functional classification of clinimetric indexes. In: Clinimetrics. New Haven, CT: Yale University Press; 1987:6-21.
36. DeVellis RF. A consumer's guide to finding, evaluating, and reporting on measurement instruments. Arthritis Care Res. 1996;9:239-245.
37. Streiner DL. Clinimetrics vs. psychometrics: an unnecessary distinction. J Clin Epidemiol. 2003;56:1142-1145; discussion 1146-1149.
38. Carr AJ, Donovan JL. Why doctors and patients disagree. Br J Rheumatol. 1998;37:1-4.
39. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.